… the risk of MB, low-dose DOACs, generally rivaroxaban 15mg or … risk of TE and MB versus
warfarin; (2) Compared to warfarin, non-… Apixaban in patients at risk of stroke undergoing atrial …

… , 92 patients received dabigatran, 103 rivaroxaban, 45 apixaban … group, because DOACs
are prescribed for non-valvular AF … consider dabigatran to be the better alternative for warfarin …

… included Japanese patients aged ≥80 years found low-dose … of rivaroxaban, apixaban and
edoxaban, but not dabigatran, … with warfarin, rivaroxaban and apixaban use in AF patients …

… Dabigatran, rivaroxaban, or edoxaban were used at lower doses, while apixaban was used
at standard dose in patients with atrial … , especially with the use of warfarin. Asians have a …

… the Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis (RIWA) studies. The RE-ALIGN
study found that dabigatran was not as effective as warfarin at … Furthermore, apixaban …

… to warfarin for stroke prevention in patients with non-valvular AF, … dabigatran compared with
that of rivaroxaban and apixaban … for the treatment of non-valvular atrial fibrillation: Why we …

… of patients treated with a low dose of dabigatran resulted in … In summary, apixaban,
rivaroxaban, and dabigatran appear to … number of non-valvular AF patients on NOACs or warfarin. …

… hemorrhage than white populations, low-dose rivaroxaban (ie, … of rivaroxaban was >90%,
whereas that of dabigatran was 35%… warfarin in Japanese patients with atrial fibrillation—the J-…

… for atrial fibrillation or patients who have previously taken … , or if their treatment was converted
to warfarin therapy. … in both groups (dabigatran 220 mg, rivaroxaban 20 mg, apixaban 5 mg, …

… warfarin, several AF guidelines have regarded NOACs (… patients with non-valvular AF
received at least off-label underdose or overdose of one NOAC (dabigatran, rivaroxaban, apixaban…